Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Rachel Leheny Insider Profile
4 Followers
Rachel Leheny, Director at Anthera Pharmaceuticals, holds 871.25K shares in CalciMedica (Ticker: CALC), holds 1.42M shares in Anthera Pharmaceuticals (Ticker: ANTH). Most recently, Rachel Leheny Bought ― shares of CalciMedica on Nov 01, 2024 for an estimated value of 75.00K.
Profitable Transactions
6 out of 11 Profitable Transactions
Average Return
+16.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Rachel Leheny holds in companies
Most Profitable Insider Trade
The most profitable trade made by Rachel Leheny
Rachel Leheny's Trading History
Anthera Pharmaceuticals
Sep 24, 2010
Director
Informative Buy
750.00K
$42.72K
CalciMedica
Nov 01, 2024
CEO, Director, Ten Percent Owner
Informative Buy
75.00K
$2.40M
List of latest transactions for each holding click on a transaction to see Rachel Leheny's performance on stock
You May Also Like
Rachel Leheny insider profile FAQ
What is the percentage of profitable transactions made by Rachel Leheny?
The percentage of profitable transactions made by Rachel Leheny is 55%.
What is the average return per transaction made by Rachel Leheny?
The average return per transaction made by Rachel Leheny is 16.70%.
What stocks does Rachel Leheny hold?
Rachel Leheny holds: ANTH, CALC stocks.
What was Rachel Leheny’s latest transaction?
Rachel Leheny latest transaction was an Informative Buy of $75.00K.
What was Rachel Leheny's most profitable transaction?
Rachel Leheny’s most profitable transaction was an Informative Buy of CALC stock on May 18, 2023. The return on the trade was 107.60%.
What is Rachel Leheny's role in Anthera Pharmaceuticals?
Rachel Leheny's role in Anthera Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.